Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma

Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA
Epcoritamab plus rituximab and lenalidomide improves efficacy in relapsed or refractory follicular lymphoma ( Dr Lorenzo Falchi - Memorial Sloan Kettering Cancer Center, New York, USA )
24 Feb 2026

Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA
Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )
5 Feb 2026

Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma

Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA
Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma ( Dr Thomas Kuczmarski - Fred Hutchinson Cancer Center, Seattle, USA )
5 Feb 2026

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA
FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC ( Dr Caio Rocha Lima - Atrium Health Wake Forest Baptist, Winston-Salem, USA )
28 Jan 2026

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform

Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA
Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform ( Dr Chiswili Yves Chabu - University of Missouri, Columbia, USA )
27 Jan 2026

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer

Dr Ricardo Pinto - i3S, Porto, Portugal
Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer ( Dr Ricardo Pinto - i3S, Porto, Portugal )
19 Jan 2026

Improving African representation in breast cancer genomics

Dr Ricardo Pinto - i3S, Porto, Portugal
Improving African representation in breast cancer genomics ( Dr Ricardo Pinto - i3S, Porto, Portugal )
19 Jan 2026

Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer

Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China
Toripalimab plus chemotherapy improves 3-year survival in resectable gastric/GEJ cancer ( Dr Shu-Qiang Yuan - Sun Yat-sen University Cancer Center, Guangzhou, China )
15 Jan 2026

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong
Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma ( Dr Stephen Chan - The Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )
15 Jan 2026

Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors

Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA
Physical activity reduces fatigue and improves quality of life in colorectal cancer survivors ( Dr Louisa Liu - Cedars-Sinai Medical Center, Los Angeles, USA )
15 Jan 2026

Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer

Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada
Zanidatamab improves PFS and OS in first-line HER2-positive metastatic gastric cancer ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )
15 Jan 2026

Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation

Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation ( Dr Antonio Jimenez Jimenez - Sylvester Comprehensive Cancer Center, Miami, USA )
15 Jan 2026